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Abstract
The purpose was to investigate the influence of RJ-F(M), 10-hydroxy-2- 
decenoic acid and HuIFN-αN3 on the proliferation of CaCo-2 cells and ascertain 
their effects on intracellular glutathione level and lipid peroxidation. The antip-
roliferative (AP) activity of RJ-F (M) (0.1 g/10 mL PBS), HuIFN-αN3 (1000 IU 
mL−1), 10-HDA (100.0 μmol L−1) and their combinations, in the ratios 1:1, 1:2, and 
2:1 on CaCo-2 cells were measured. Single RJ-F (M) had a low AP activity: 2.0 (0.5 
mg mL−1). HuIFN-αN3 had an AP activity of 2.5 (208.33 IU mL−1), while 10-HDA 
had an AP activity of 1.5 (37.5 μmol mL−1). AP activity of 3.8 was obtained when 
RJ-F(M) and HuIFN-αN3 were in the ratio 2:1. In it, the level of GSH was 24.9 ± 2.4 
nmol g−3 of proteins (vs. 70.2 ± 3.2 nmol g−3 in the control), and  level of MDA was 
72.3 ± 3.1 nmol g−3 (vs. 23.6 ± 9.1 nmol g−3 in the control). 10-HDA, together with 
HuIFN-αN3, is responsible for the inhibition of CaCo-2 cell proliferation in vitro. 
RJ-F (M) and HuIFN-αN3 applied at 2:1 decreased level of GSH and increased lipid 
peroxidation via MDA in CaCo-2 cells. Future studies are needed whether these 
GSH- and MDA-related activities of RJ-F (M), HuIFN-αN3, 10-HDA, and their 
combinations may decrease the tumorigenicity index and tumorigenic potential of 
tumor cells in vitro
Keywords: antiproliferative activity, antitumor activity, CaCo-2 cells,  
10-hydorxy-2-decenoic acid, malondialdehyde, HuIFN-αN3, RJ-F (M)
1. Introduction
Royal jelly (RJ) is a milky acid colloid of a pH between 3.6 and 4.2, produced 
by hypo pharyngeal and mandible glands of young worker bees between sixth and 
twelfth days of their life. Fed as a sole nutrient, it is the exclusive food for the bee 
colonies’ queen honey bee (Apis mellifera) larva, developing into a sexual mature 
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queen bee. RJ has a crucial role in the life span of bees: worker bee lives around 
45 days, while a queen bee can be alive up to 5 years. During this time, she is able to 
spawn daily an equivalent of her body weight in eggs (approximately 2000–3000 
eggs/day for up to 5 years) [1, 2]. Chemically, RJ is composed by water (50–60%), 
different proteins (18.0%), carbohydrates (15.0%), lipids (3–6%), mineral salts 
(1.5%), and vitamins, together with bioactive substances, such as 10-hydroxy-2-dec-
enoic (10-HDA) acid [3]. 10-HDA exerts an inhibitory effect on vascular endothelial 
growth factor-induced angiogenesis in cellular models of tumor growth, partly by 
inhibiting cell proliferation and migration [4]. RJ contains different immunomodu-
lative and antiproliferative substances as well as substances with possible antitumor 
activities. It also contains proteins, like 350-kDa protein, that stimulate proliferation 
of human monocytes [5–7]. In addition, RJ protein30 can be found; it has shown 
an prominent cytotoxic effect on HeLa cells in vitro [8]. A protein component of 
RJ belong to the family of major royal jelly proteins (MRJPs) or an albumin. In 
this families, eight proteins (MRJP 1–8) were identified and found that they have 
molecular masses between 49 and 87 kDs. MRJPs have an important role in the diet 
of the queen bee [9]. Other proteins in RJ that are in much lower amount are royali-
sin, jelleines, aspimin, and royalactin. Researchers showed antibacterial properties 
of royalisins against Gram-positive bacteria and proposed their use as potential anti-
microbial [10]. Royalisins are composed of 51 residues with a net charge of +2; even 
their origin is unknown. It was supposed that they could originate directly from 
honeybee. It was also shown that the RJ’s protein royalactin is needed for queen bee 
differentiation. It activates the epidermal growth factor receptor (EGFR) signaling 
pathway in honeybee larvae, which leads to queen development. Corona et al. [11] 
found that royalactin induces queen development through shortening her develop-
ment time and increases longevity of the queen bee by the EGFR signaling pathway.
In RJ, glucose oxidase enzyme (GOx) was also detected. GOx catalyzing the 
oxidation of glucose to hydrogen peroxide was showing a relatively high antibacte-
rial activity [12].
Interferons (IFNs) are multifunctional glycoproteins/proteins produced and 
released by host cells in response to the presence of pathogens such as viruses, 
bacteria, parasites, or tumor cells. There are three classes of IFNs, designated as 
Types I, II, and III. HuIFN-αN3, a Type I interferon, is a protein composed from 
13 subtypes [13, 14] having antiviral, antiproliferative, and antitumor activities 
[15]. Type I IFN isoforms were found since its discovery. These, coded by a single 
exon, include IFN-α (composed from 13 subtypes: IFN-α1, IFN-α2, IFN-α4, IFN-α5, 
IFN-α6, IFN-α7, IFN-α8, IFN-α10, IFN-α13, IFN-α14, IFN-α16, IFN-α17, and IFN-
α21), IFN-β, IFN-ε, IFN-κ, and IFN-ω [16]. The latter was used from the beginning 
for the treatment of different forms of cancers, despite its molecular mechanism 
of cytoreductive action being far from clear. HuIFN-αN3’s antiproliferative activ-
ity plays a central role in its chemotherapeutic effect. The research explained its 
action in apoptosis as a way of antitumor action [17]. In addition, HuIFN-αN3 
shows a direct cytotoxic effect on malignant cells and different tumor cell lines 
in vitro [18]. It was also shown that endogenous type I IFN prevents the growth of 
primary carcinogen-induced and transplantable tumors [19]. One of the earliest 
described immunoregulatory functions of HuIFN-αN3 is its ability to regulate NK 
cell functions that is one of the major mechanisms of regulation of tumor growth 
by the endogenous type I IFN. The role of HuIFN-αN3 in regulating tumor cell 
proliferation, apoptosis, and autophagy was only recently begun to be investigated 
in depth [20]. In addition, the ability of oncogenes such as Ras and HPV16 E6E7 for 
downregulating the IFN-inducing innate receptors, RIG-I and TLR9, is a suggestion 
for a role of HuIFN-αN3 in modulating the infectiveness of cell-transforming ability 
of oncogenic viruses [21].
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The low-molecular-weight thiol, glutathione (GSH) with a role in the control of 
the thiol/disulfide redox state in the cells, is important for cellular redox signaling 
and also for CaCo-2 cells. Intracellular concentration of GSH, cell proliferation, 
and apoptosis are mutually connected. GSH in a relatively high level enhances the 
cell proliferation. In contrary, its depletion results in the inhibition of CaCo-2 cell 
growth and proliferation, because of the increase of apoptosis [22].
Oxidative degradation of lipids or lipid peroxidation (LP) is a process where free 
radicals “rob” electrons from cellular membrane lipids and induce cell damage by 
proceeding with the free radical chain reaction mechanism. The LP’s end products 
are reactive aldehydes with a relatively strong carcinogenic potential.
Malondialdehyde (MDA) is one of the important reactive aldehydes. It is a bioac-
tive marker of the LP with a different biological activity similar to reactive oxygen 
species [23, 24].
The aim of the present study was to explore the effect of RJ-F (M) and 10-HDA 
on the HuIFN-αN3-induced inhibition of CaCo-2 cell proliferation in vitro. Also 
important is to ascertain their influence on the level of the GSH in the cells and 
also on the lipid peroxidation via the MDA activity. Such an experimental approach 
might serve to explain some of the antiproliferative/antitumor mechanisms in 
CaCo-2 cells. All this could be also important for the developing of future antipro-
liferative treatments based on the use of the mentioned bioactive compounds.
2. Materials and methods
2.1 Materials
During the experiments, the following materials were used: (1) HuIFN-αN3 
(Institute of Immunology, Zagreb, Croatia) was applied at 1000 IU mL−1. This 
concentration was found in our previous experiments [25]. (2) Fresh royal jelly 
(Mižigoj) (RJ-F (M)) (Medex D.o.o., Ljubljana, Slovenia) was applied in a concentra-
tion of 0.1 g/10 mL [26]. (3) 10-hydroxy-2-decenoic acid (10-HDA) (Sigma-Aldrich, 
Missouri, USA) was applied in a concentration of 100 μmol L−1 [27–29]. All reagents 
were dissolved in phosphate buffer saline (PBS) having a pH of 7.2, centrifuged at 
2500 g (Centric, Tehtnica D.o.o., Železniki, Slovenia) for 15 minutes, and the super-
natants were sterilized by filtration through 0.2 μm syringe filter (Millipore, USA). 
Sterilized reagents were stored on −20°C until their use in the experiments.
2.2 Cell culture
CaCo-2 cells were cultivated in a complete Eagle’s medium supplemented with 
10% of fetal calf serum (FCS) (Sigma-Aldrich, Missouri, USA). The cells were mul-
tiplied before the experiments, so that their viability and capability for proliferation 
can be assayed with MTT Cell Proliferation Assay Kit (K299-100) (BioVision, 
Milpitas, California, USA). In performed tests, positive cells were further cultivated 
in a 96-well flat microtiter plates (Sterilin, Sigma-Aldrich, Missouri, USA) or in 
25 cm2 flasks (Sterilin, Sigma-Aldrich, Missouri, USA) in 5% CO2 at 37°C until the 
monolayer appeared before they can be used for the experiments.
2.3 The studies’ design
The experiments were designed as follows: (1) RJ-F (M), HuIFN-αN3, and 
10-HDA in the previously stated concentrations were added alone in a volume of 
100 μL/well. (2) In various combinations between them (RJ-F (M), HuIFN-αN3, 
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and 10-HDA) for ratio 1:1, 100 + 100 μL/well were added. For ratio 1:2, 
66.8 + 133.2 μL/well were added, and for ratio 2:1, 133.2 + 66.8 μL/well were added.
2.4 Antiproliferative (AP) activity
In the AP assay that was performed in a way according to Sugarman et al. 
[30], single substances RJ-F (M), HuIFN-αN3, and 10-HDA and their combina-
tions in ratios 1:1, 1:2, and 2:1 were added. In the first well in a row of a 96-well 
microtiter plate, 200 μL of sample volume was added. This was serially trans-
ferred per 100 μL from 1:2 to 1:4096. To these, CaCo-2 cells in a concentration of 
104 cells/well/100 μL in a complete Eagle’s medium with 10% FCS were added. 
Separately, with CaCo-2 cells without being added alone or in their combinations 
of 1:1, 1:2, and 2:1, substances served as the negative control. The single tested 
substances RJ-F (M), HuIFN-αN3, and 10-HDA were used as a positive control. 
Microtiter plates with substances, as single or in combinations 1:1, 1:2, and 2:1, 
and CaCo-2 cells were incubated for 72 hours at 37°C in a 5% CO2 atmosphere. 
Afterward, the supernatants were discarded, and cells were fixed with 100 μL/
well of 10% formalin (Sigma-Aldrich, Missouri, USA) in PBS. After 2 hours, the 
fixative was removed and cells washed twice with the PBS. Then, 2% Rhodamine 
(Sigma-Aldrich, Missouri, USA) in a volume of 100 μL/well was added for 
15 minutes. This was then removed, and the cells were washed twice with the 
PBS and air-dried. Optical density (OD) at 550 nm was measured on dried 
microtiter plates on the Synergy HTX Multi-Mode Reader with Gen 5 software 
(Biotek, Winooski, USA). The AP activities was determined with the well in rows 
where 50% cell growth inhibition were found. The AP50 was calculated for each 
separate substance (RJ-F (M), HuIFNαN3, and 10-HDA) or their combinations 
(1:1, 1:2, and 2:1).
2.5 Glutathione (GSH) determination
According to Watson et al. [24], the GSH assay was performed. The CaCo-2 cells 
were cultivated in flasks having 25 cm2 (Sterilin, Sigma-Aldrich, Missouri, USA) in 
a complete Eagles’ medium with 10% FCS. To the monolayer of CaCo-2 cells, the 
substances of RJ-F (M), HuIFN-αN3, and 10-HAD alone in volumes of 1.0 mL, or 
their combinations of 1:1, 1:2, and 2:1 in volumes of 2.0 mL, were added. The treat-
ment took place for 24 hours at 37°C and 5% CO2. Then, the cells were removed by 
Trypsin (Sigma-Aldrich, Missouri, USA) and treated with 1 mL of mmol mL−1 Tris–
HCl solution (pH = 6.0) containing 0.5 mol mL−1 diethylene triamine pentacetic 
acid (DTPA) (Sigma-Aldrich, Missouri, USA). After such treatment, the cells were 
lysed by the syringing through the insulin syringe. The quantities of total cellular 
proteins were determined by the Bio-Rad protein assay (Bio-Rad Laboratories, 
Hercules, California, USA) having a standard bovine serum albumin (BSA) (Sigma-
Aldrich, Missouri, USA).
To determine the amount of GSH, 50 μL of the lysed CaCo-2 cells, 100 μL 
of 25 μmol L−1 DL-Dithiothreitol (DTT),  and 150 μL of 0.1 mol mL−1 Tris-HCl 
(pH 8.5) were added. This mixture was incubated for 30 minutes on ice. Then, 
750 μL of 2.5% (wt. /vol) 5-sulfosalicylic acid was added to precipitate proteins. 
The precipitate was centrifuged at 13000 g (Centric, Tehtnica D.o.o., Železniki, 
Slovenia) for 5 minutes at 4°C, and the supernatants were used in GSH Assay Kit 
(Sigma-Aldrich, Missouri, USA) to measure the GSH level at OD at 412 nm on 
Synergy HTX Multi-Mode Reader with Gen 5 software (Biotek, Winooski, USA) 
and express it as nmol of GSH g−3/proteins.
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2.6 Lipid peroxidation assay
CaCo-2 cells were cultivated in 25 cm2 flasks (Sterilin, Sigma-Aldrich, Missouri, 
USA) in a complete Eagles’ medium with 10% FCS in 5% CO2 and 37°C. When 
monolayer was formed, the cells were treated with substances either alone or 
their combinations as described previously, in a quantity of 1.0 mL when single 
substances were added, and a total of 2.0 mL when their combinations (1:1, 1:2, 
and 2:1) were added. The cells were incubated for 24 hours at 37°C and 5% CO2. 
The medium was removed, and cells were detached with trypsin, washed, and 
resuspended in 5 mL of PBS. The total cell protein concentration was determined by 
the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, California, USA) with a 
BSA as a standard. A measure of 1 mL of thiobarbituric acid (TBA) reagent (0.38% 
2-TBA, 15.0% TBA, 0.3 mol mL−1HCl) was added to the cell suspension, and these 
were heated at 95°C for 20 minutes, chilled to room temperature, and centrifuged at 
1500 g for 10 minutes (Centric, Tehtnica d.o.o., Železniki, Slovenia). The quantity 
of TBA reactive substances (RS) developed by lipid peroxidation was measured at 
OD at 535 nm in Synergy HTX Multi-Mode Reader with Gen 5 software, (Biotek, 
Winooski, USA). The obtained results were expressed as MDA nmol g−3 of protein.
2.7 Statistical evaluation
For statistical significance determination (*p < 0.1, **p < 0.05), the t-test was 
used. All the data are shown as a mean value ± standard deviation. The tests were 
performed in triplicate, and each was repeated three to four times.
3. Results and discussion
3.1 Antiproliferative (AP) activity
The results of AP activity and their concentrations at AP50 in case of single 
substances were found as follows: RJ-F (M), 0.157 (0.5 mg mL−1); HuIFN-αN3, 
0.741 (208.33 IU mL−1; and 10-HDA, 0.487 (37.5 μmol L−1). The AP activities of 
used single substances (RJ, HuIFN-αN3, and 10-HDA) were relatively low. Such AP 
activity expressed as growth rate index (GRI) of their combinations (1:1, 1:2, 2:1) is 
shown in Figure 1.
When a combination between RJ-F (M) and HuIFN-αN3 in ratio 2:1 was used, the 
highest AP activity was found. Their AP activity expressed as GRI was 1.006. The com-
binations of 10-HDA and HuIFN-αN3 2:1 show the AP activity expressed as GRI 0.952, 
which was lower than this in combination of RJ-F (M) and HuIFN-αN3 (2:1). These 
results suggest that RJ-F (M) should contain some other components responsible for 
the relatively strong AP activity of the combination of the RJ-F (M) and HuIFN-αN3 
(2:1). The RJ protein30, a water soluble fraction showing the cytotoxic effect on the 
HeLa cells by decreasing the cell population by 50%, should be taken into account.
The AP activity of RJ-F (M), HuIFN-αN3, and 10-HDA on the CaCo-2 cells is 
connected to the induction of apoptosis and cytotoxicity. They also influence the 
glutathione level and lipid peroxidation in CaCo-2 cells [31].
3.2 GSH determination and measurement of lipid peroxidation via MDA
The results obtained in our study show that RJ-F (M), HuIFN-αN3, 10-HDA, and 
their combinations (1:1, 1:2, and 2:1) decreased the intracellular level of the GSH 
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and increased the lipid peroxidation via the MDA. The data in extent are shown in 
Figure 2 and Table 1.
The GHS has an important role in various intracellular processes like cellular 
differentiation, proliferation, apoptosis, and cancer. The decrease of the GSH/
glutathione disulfide (GSSG) ratios consequently lead to the enhanced susceptibil-
ity to oxidative stress and the progression of cancer. In addition, the increased GSH 
levels enhance the antioxidant capacity and resistance to oxidative stress that can 
be found in transformed cells. Some of the possible antitumor mechanisms of RJ-F 
(M) are linked to the modulation of the oxidative stress and induction of apoptosis 
[32]. Similar effects were found during the treatment of the PaCa-44 cells with 
10-HDA, where induction of the apoptosis was also confirmed [33]. Furthermore, 
the antitumor activity of the HuIFN-αN3 is connected with the induction of apop-
tosis and the modulation of the oxidative stress in rats having breast cancer [34].
Figure 1. 
The antiproliferative (AP) effect expressed as growth rate index (GRI = GRin.−GR8d/GR8d) of RJ-F (M), 
HuIFN-αN3, 10-HDA, and their combinations: 1:1, 1:2, and 2:1 on the CaCo-2 cells. The inhibition of 
proliferation of CaCo-2 cells treated with RJ-F (M) (0.1 g/10 mL PBS), HuIFN-αN3 (1000 IU mL−1), 10-HDA 
(100 μmol mL−1), and different combinations between them (1:1, 1:2, and 2:1) were analyzed. The AP activity 
was determined by Rhodamine B staining method after 72 hours of incubation at 37°C and 5% CO2.
Figure 2. 
The percent of CaCo-2 cell control value of glutathione (GSH) or malondialdehyde (MDA) after treatment 
with RJ-F (M), HuIFN-αN3, 10-HDA, and different combinations between them (1:1, 1:2, and 2:1).
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The 10-HDA, the most important constituent of the RJ-F (M) and HuIFN-αN3, 
had a complementary active point due to its antitumor activity, which can be 
enhanced when they were combined in a proper ratio. The most effective was 
the ratio of 2:1 of the RJ-F (M) and HuIFN-αN3. Using this, the level of GSH was 
24.9 ± 2.4 nmol g−3, and the level of MDA was 72.3 ± 3.1 nmol g−3. The following 
were the control values: for GSH it was 70.2 ± 3.2 nmol g−3 and for MDA it was 
23.6 ± 9.1 nmol g−3. The RJ-F (M) and HuIFN-αN3 applied at 2:1 ratio and HuIFN-
αN3 applied in combination with 10-HDA in 2:1 ratio caused a decrease in the level 
of GSH and increase in lipid peroxidation indicator level (MDA) in CaCo-2 cells in 
Table 1. 
Glutathione (GSH) determination and the measurement of lipid peroxidation (MDA) after the CaCo-2 cell 
treatment with RJ-F(M), HuIFN-αN3, 10-HDA, and their combinations of 1:1, 1:2, and 2:1.
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comparison with the control group. On the other hand, it was observed that these 
combinations had the highest antiproliferative effect. In addition, it is suggested 
that antiproliferative effects of RJ-F (M), HuIFN-αN3, and 10-HDA on the CaCo-2 
cells can be connected not only with the induction of apoptosis and cytotoxicity but 
also with their influence on the pro- and anti-oxidative balance [35].
4. Conclusion
Future experiments will show whether these GSH- and MDA-related activi-
ties of the RJ-F (M), HuIFN-αN3, 10-HDA, and their combinations may cause the 
decrease of the tumorigenicity index of different tumor cells in vitro as a result of 
their tumorigenic potential, as it has already been reported in the literature [36–39]. 
This is important for practical use of the RJ-F (M), 10-HDA, and HuIFN-αN3 in 
a proper combination that could be of value for future development of possible 
tumor therapy based on the use of these bioactive compounds.
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